Gara Jalqabaatti › Kansarii Ovarii › Virginia › Charlottesville
Qorannoo klinikaalii Kansarii Ovarii Charlottesville, VA keessatti
Qorannoo 10 Kansarii Ovarii f Charlottesville fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
The Vanguard Study: Testing a New Way to Screen for Cancer
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- Sentara Martha Jefferson Hospital, Charlottesville
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Namoota walitti qabaa jiraSadarkaa 2
- University of Virginia Cancer Center, Charlottesville
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- University of Virginia, Charlottesville
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Namoota walitti qabaa jiraSadarkaa 2
- UVA Health University Hospital /ID# 275309, Charlottesville
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Namoota walitti qabaa jiraSadarkaa 3
- University of Virginia Health System, Charlottesville
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- University of Virginia, Charlottesville
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Namoota walitti qabaa jira
- University of Virginia Cancer Center, Charlottesville
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 3
- University of Virginia Cancer Center, Charlottesville
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Namoota walitti qabaa jiraSadarkaa 2/3
- University of Virginia Comprehensive Cancer Center, Charlottesville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Charlottesville
Qorannoo Kansarii Ovarii magaalota biroo keessatti
- Houston, TXQorannoo 89
- New York City, NYQorannoo 69
- Boston, MAQorannoo 61
- Los Angeles, CAQorannoo 50
- Nashville, TNQorannoo 49
- Arlington, VAQorannoo 46
- Philadelphia, PAQorannoo 44
- Columbus, OHQorannoo 39
- St. Louis, MOQorannoo 38
- Chicago, ILQorannoo 36
- San Antonio, TXQorannoo 31
- Cleveland, OHQorannoo 30
Qorannoo biroo Charlottesville keessatti
- Kansara Qara'a Non-Small CellQorannoo 21
- Leukemia Myeloidii HamaaQorannoo 16
- Kansarii ProstateQorannoo 15
- Saree (Gosoota Hunda)Qorannoo 13
- Kansa EndometiriyaaliiQorannoo 13
- Kansara MetastatikiiQorannoo 13
- Dhibee QaraQorannoo 13
- Cufama OnneeQorannoo 12
- Kansarii ColorectalQorannoo 10
- Diabetes Type 1Qorannoo 9
- Saree OljooQorannoo 9
- Kansarii PancreasQorannoo 9
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.